IMRX Insider Trading

Insider Ownership Percentage: 23.00%
Insider Buying (Last 12 Months): $266,645.33
Insider Selling (Last 12 Months): $3,053,818.52

Immuneering Insider Trading History Chart

This chart shows the insider buying and selling history at Immuneering by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Immuneering Share Price & Price History

Current Price: $1.47
Price Change: Price Increase of +0.04 (2.80%)
As of 04/26/2024 09:52 PM ET

This chart shows the closing price history over time for IMRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Immuneering Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/1/2024Cormorant Asset Management, LpMajor ShareholderSell400,000$2.90$1,160,000.002,895,273View SEC Filing Icon  
3/22/2024Harold Eugene BrakewoodInsiderBuy3,900$2.57$10,023.003,900View SEC Filing Icon  
3/22/2024Peter FeinbergDirectorBuy25,000$2.55$63,750.00111,766View SEC Filing Icon  
3/21/2024Mallory MoralesCAOBuy1,107$2.72$3,011.047,885View SEC Filing Icon  
3/20/2024Leah R NeufeldInsiderBuy3,818$2.88$10,995.8410,029View SEC Filing Icon  
3/19/2024Benjamin J ZeskindCEOBuy20,000$2.77$55,400.002,281,852View SEC Filing Icon  
3/18/2024Ann E BermanDirectorBuy57,965$2.13$123,465.4567,465View SEC Filing Icon  
3/14/2024Cormorant Asset Management, LpMajor ShareholderSell509,091$3.72$1,893,818.523,695,273View SEC Filing Icon  
5/25/2022Brett Matthew HallInsiderBuy2,551$3.92$9,999.92332,685View SEC Filing Icon  
5/17/2022Michael BookmanGeneral CounselBuy1,000$4.88$4,880.002,402View SEC Filing Icon  
5/16/2022Laurie KeatingDirectorBuy7,000$5.00$35,000.0014,000View SEC Filing Icon  
5/12/2022Biren AminCFOBuy1,000$4.42$4,420.007,898View SEC Filing Icon  
3/23/2022Benjamin J ZeskindCEOBuy3,000$8.02$24,060.00View SEC Filing Icon  
3/22/2022Scott BarrettInsiderBuy900$7.49$6,741.00View SEC Filing Icon  
3/15/2022Ann E BermanDirectorBuy6,000$6.40$38,400.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Immuneering (NASDAQ:IMRX)

67.65% of Immuneering stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at IMRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Immuneering Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/12/2024TD Asset Management Inc197,876$1.45M0.0%-30.4%0.676%Search for SEC Filing on Google Icon
1/5/2024Exchange Traded Concepts LLC17,416$0.13M0.0%+34.0%0.060%Search for SEC Filing on Google Icon
11/15/2023Adage Capital Partners GP L.L.C.195,000$1.50M0.0%+11.4%0.666%Search for SEC Filing on Google Icon
11/14/2023Corton Capital Inc.18,847$0.15M0.1%N/A0.064%Search for SEC Filing on Google Icon
11/13/2023Southport Management L.L.C.17,500$0.13M0.7%N/A0.060%Search for SEC Filing on Google Icon
11/13/2023FMR LLC612,168$4.70M0.0%-7.0%2.092%Search for SEC Filing on Google Icon
11/13/2023PNC Financial Services Group Inc.20,000$0.15M0.0%N/A0.068%Search for SEC Filing on Google Icon
10/27/2023TD Asset Management Inc284,476$2.19M0.0%+100.0%0.972%Search for SEC Filing on Google Icon
10/18/2023Exchange Traded Concepts LLC12,999$100K0.0%-12.7%0.044%Search for SEC Filing on Google Icon
9/8/2023Tucker Asset Management LLC11,036$0.11M0.0%N/A0.038%Search for SEC Filing on Google Icon
8/15/2023HighVista Strategies LLC253,110$2.57M1.2%N/A0.865%Search for SEC Filing on Google Icon
8/14/2023Cormorant Asset Management LP4,204,364$42.63M2.4%+76.2%14.369%Search for SEC Filing on Google Icon
8/11/2023ExodusPoint Capital Management LP127,719$1.30M0.0%+48.0%0.436%Search for SEC Filing on Google Icon
8/9/2023TD Asset Management Inc142,238$1.44M0.0%-1.3%0.486%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.9,761$99K0.0%N/A0.033%Search for SEC Filing on Google Icon
8/2/2023Bank of Montreal Can714,037$8M0.0%N/A2.441%Search for SEC Filing on Google Icon
7/26/2023Janney Montgomery Scott LLC22,135$0.22M0.0%N/A0.076%Search for SEC Filing on Google Icon
7/20/2023Exchange Traded Concepts LLC14,884$0.15M0.0%N/A0.051%Search for SEC Filing on Google Icon
5/11/2023ExodusPoint Capital Management LP86,297$0.84M0.0%N/A0.295%Search for SEC Filing on Google Icon
5/9/2023Y Intercept Hong Kong Ltd11,114$0.11M0.0%N/A0.038%Search for SEC Filing on Google Icon
11/15/2022Citadel Advisors LLC2,184,909$31.29M0.0%-0.7%8.273%Search for SEC Filing on Google Icon
8/4/2022TD Asset Management Inc.147,661$0.80M0.0%+21.8%0.560%Search for SEC Filing on Google Icon
5/10/2022TD Asset Management Inc.121,201$0.78M0.0%+253.4%0.459%Search for SEC Filing on Google Icon
2/15/2022Adage Capital Partners GP L.L.C.314,000$5.08M0.0%N/A1.210%Search for SEC Filing on Google Icon
2/14/2022Citadel Advisors LLC2,058,102$32.04M0.0%+0.1%7.934%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp75,891$1.23M0.0%+4.5%0.293%Search for SEC Filing on Google Icon
2/2/2022New York State Common Retirement Fund4,637$75K0.0%+172.8%0.018%Search for SEC Filing on Google Icon
1/28/2022Allspring Global Investments Holdings LLC9,228$0.15M0.0%N/A0.036%Search for SEC Filing on Google Icon
12/3/2021Perceptive Advisors LLC681,051$18.08M0.3%N/A2.625%Search for SEC Filing on Google Icon
11/16/2021Suvretta Capital Management LLC200,000$5.31M0.1%N/A0.771%Search for SEC Filing on Google Icon
11/16/2021Metropolitan Life Insurance Co NY2,814$75K0.0%N/A0.011%Search for SEC Filing on Google Icon
11/16/2021Millennium Management LLC89,788$2.38M0.0%N/A0.346%Search for SEC Filing on Google Icon
11/16/2021Citadel Advisors LLC2,055,459$52.40M0.0%N/A7.924%Search for SEC Filing on Google Icon
11/15/2021Rock Springs Capital Management LP1,089,816$28.94M0.6%N/A4.201%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP13,149$0.35M0.0%N/A0.051%Search for SEC Filing on Google Icon
11/15/2021Caas Capital Management LP40,000$1.06M0.0%N/A0.154%Search for SEC Filing on Google Icon
11/12/2021Ghisallo Capital Management LLC15,000$0.40M0.0%N/A0.058%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC122,319$3.25M0.0%N/A0.472%Search for SEC Filing on Google Icon
11/10/2021Citigroup Inc.1,246$33K0.0%N/A0.005%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.1,524,374$40.47M0.0%N/A5.877%Search for SEC Filing on Google Icon
11/9/2021TD Asset Management Inc.34,296$0.91M0.0%N/A0.132%Search for SEC Filing on Google Icon
11/4/2021Deutsche Bank AG4,752$0.13M0.0%N/A0.018%Search for SEC Filing on Google Icon
11/2/2021New York State Common Retirement Fund1,700$45K0.0%N/A0.007%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Immuneering logo
Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 is in Investigational New Drug application to treat solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.
Read More on Immuneering

Today's Range

Now: $1.47
Low: $1.43
High: $1.51

50 Day Range

MA: $3.70
Low: $1.43
High: $6.76

52 Week Range

Now: $1.47
Low: $1.40
High: $11.92

Volume

295,700 shs

Average Volume

561,312 shs

Market Capitalization

$43.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Immuneering?

Immuneering's top insider shareholders include:
  1. Cormorant Asset Management, Lp (Major Shareholder)
  2. Benjamin J Zeskind (CEO)
  3. Brett Matthew Hall (Insider)
  4. Peter Feinberg (Director)
  5. Ann E Berman (Director)
  6. Laurie Keating (Director)
  7. Leah R Neufeld (Insider)
  8. Biren Amin (CFO)
  9. Mallory Morales (CAO)
  10. Harold Eugene Brakewood (Insider)
  11. Michael Bookman (General Counsel)
Learn More about top insider investors at Immuneering.